Fundraising FoxJohnson & Johnson Innovation – JJDC — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.
BiotechDeep TechHealthtechMedical Devices
Catherine Pickering(Co-Founder & CEO)inLars van der Veen(Co-Founder & CSO)inMichael Lahn(CMO)inElizabeth Holt(CBO)inSteven Sciuto(CFO)inMichelle Tsai(COO)in
Co-investorsInkef3B Future Health FundM VenturesVI PartnersXGEN Venture
Modern nail care brand offering high-quality, salon-grade products and tools for at-home manicures and pedicures.
Beverly Hills, US
Sarah Gibson Tuttle(Executive Officer, Director)in
Co-investorsAlpha Edison
Rosebud AI provides generative AI tools that enable users to create games and immersive interactive experiences without requiring extensive technical expertise.
AI & Machine LearningConsumerCreator EconomyDeveloper ToolsGamingSan Francisco, US
Lisha Li(Founder)inMei Liu(Eng Lead)Dzmitry Pletnikau(Founding Engineer)Eric Liu(Intern)Alexandru Barbur(Head of Eng)Kat Dar(EA)
Co-investors2am VCAngel Collective Opportunity FundFoothill VenturesKhosla VenturesSoma CapitalVentek+15 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.